Fremanezumab, Migraine and Sleep
NCT04693533
·
clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
22
Enrollment
OTHER
Sponsor class
Stopped
poor enrollment
Conditions
Migraine Disorders
Sleep Disorder
Interventions
DRUG:
Fremanezumab Prefilled Syringe [Ajovy]
Sponsor
Beth Israel Deaconess Medical Center
Collaborators
[object Object]